Advancing Discovery Together
At Immuto Scientific, we collaborate with leading biopharma, academic, and technology partners to unlock structural insights that accelerate discovery.
Uncovering New Targets
We collaborate on mutually interesting therapeutic areas to deepen understanding of target biology and mechanism of action. Our collaboration-to-license framework enables partners to translate structural discoveries into validated targets for specific indications.
Turning Structural Data into Discovery
Immuto’s unique solution-state structural data bridges molecular structure and AI — enabling “structure-at-omic-scale” insights. We partner with data and AI-driven organizations to integrate structural intelligence into predictive discovery workflows.
